文献速递静脉血栓栓塞

阿加曲班后达比加群治疗肝素诱导血小板减少症伴血栓:病例系列与文献综述

Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
PubMed 文献 · Ann Vasc Surg · 2021-10-14

本文报告5例肝素诱导血小板减少症(HIT)伴深静脉血栓患者,经阿加曲班治疗后改用达比加群,血小板逐渐恢复正常,90天随访内无新发症状性动静脉血栓栓塞,但1例出现胃出血并死亡。结合文献综述提示达比加群可能有效,但需警惕出血风险。

要点

  • 阿加曲班后序贯达比加群可使HIT患者血小板逐渐恢复至正常范围。
  • 90天随访内未见新发症状性、客观证实的动静脉血栓栓塞。
  • 需警惕严重出血并发症,如病例3的胃出血并最终死亡。

核心结论

  • 阿加曲班后使用达比加群可能对HIT伴深静脉血栓患者有效,但需重新考虑安全性,因观察到严重并发症。

研究设计与样本

  • 病例系列描述5例HIT伴深静脉血栓患者,并综述代表性病例和文献探讨NOACs治疗HIT的有效性与安全性。

主要发现

  • 达比加群治疗后血小板逐渐升高并最终达到正常范围。
  • 90天随访期内无新发症状性、客观证实的动静脉血栓栓塞发生。
  • 病例3在达比加群治疗后出现胃出血并最终死亡。

临床怎么用

  • 对HIT伴血栓患者,阿加曲班后序贯达比加群可能是一种治疗选择,但需密切监测出血风险。

局限性

  • 病例系列样本量小,仅为5例,结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is immune-mediated thrombotic thrombocytopenia following the use of heparin, which contributes to a high limb-amputation rate and mortality if not appropriately handled. There is growing evidence suggesting that novel oral anticoagulants (NOACs) may be effective for treating HIT. METHODS: We described five rare cases of patients with HIT associated with deep vein thrombosis treated with dabigatran, a member of NOACs. We also reviewed representative cases and literature investigating the use of NOACs to treat patients with HIT to further discuss the efficacy and safety. RESULTS AND CONCLUSIONS: Following the treatment of dabigatran after argatroban, the platelet count of patients with HIT gradually elevated and reached the normal range eventually. There was no incidence of new symptomatic, objectively-confirmed arteriovenous thromboembolism observed within the 90-day-period follow up. The patient in case 3 presented with gastric bleeding after dabigatran treatment and died in the end. The results suggested that dabigatran use after argatroban may be effective in the treatment of patients with HIT. However, safety should be reconsidered since severe complications were observed in case 3.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang Y, Zhang K, Yin L, et al. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review. Ann Vasc Surg. 2021. PMID: 34656708. doi:10.1016/j.avsg.2021.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。